Dr Reddy’s Lab acquires 79.4% stake in Octoplus

07 Jan 2013 Evaluate

In the process of acquiring 100% stake in Netherlands-based specialty pharmaceutical company OctoPlus NV, Dr Reddy’s Laboratories has, so far, acquired 79.4% stake of Octoplus. Of the aforementioned stake, the company has bought 15.9% shares (83,59,858 shares) through open market and 63.5% shares (3,34,48,839 shares) were committed by certain members of the OctoPlus Board and other shareholders though irrevocable undertaking.

The entire acquisition is expected to be completed by the end of the current financial year. As per the agreement, Dr Reddy’s made an open offer to purchase all outstanding shares of OctoPlus at an offer price of 0.52 euro in cash for each share.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×